As Eli Lilly awaits an FDA approval decision for its oral GLP-1 orforglipron, the pharma has discarded three clinical-stage drugs, including a gene therapy from its $1 billion acquisition of Prevail ...

Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...

Study suggests that persistently activated ATF6α is a tumor driver, a potential stratification marker for immunotherapy response, and a therapeutic target for HCC.

UVA scientists discovered a molecule that blocks a key gene that drives glioblastoma, offering hope for a new treatment ...

Monash University researchers, in collaboration with Harvard University, have discovered how to permanently "switch off" ...

Ovarian cancer standard of care has not advanced in over 30 years, but a new DNA-based immunotherapy could be a gamechanger, showing major survival gains in clinical trials.

By targeting three key growth pathways at once, researchers eliminated pancreatic tumors in multiple mouse models and ...

QIMR Berghofer scientists have discovered a cancer-fighting RNA molecule that could hold the key to a new way of treating the ...

UVA Comprehensive Cancer Center scientists have identified a molecule that blocks the gene responsible for glioblastoma, ...

Key opportunities in the gene therapy market include treating genetic disorders and cancer, driven by rising FDA approvals and biotechnological advancements. The in vivo segment, cancer treatments, ...

Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.